Stance Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Stance Capital's IDXX Position: Q3 2026 in Review
Stance Capital held its Idexx Laboratories (IDXX) position steady in Q3 2026 at 400 shares worth $209K. The position accounts for 0.07% of the portfolio, ranked #139.
Stance Capital first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.46M in Q3 2025. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Stance Capital held 400 shares of Idexx Laboratories worth $209K as of Q3 2026.
- Stance Capital left its Idexx Laboratories share count unchanged in Q3 2026.
- Idexx Laboratories made up 0.07% of Stance Capital's portfolio in Q3 2026, its #139 holding.
- Stance Capital first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
- Stance Capital's Idexx Laboratories position peaked at $4.46M in Q3 2025.
- 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Stance Capital's 13F filing for Q3 2026, filed 16 Nov 2026.